Outcomes of buprenorphine maintenance in office-based practice

Journal of Addictive Diseases

Volumn 26, Issue 2, 2007, Pages 13-23

  Magura, Stephen ^a   Lee, Stephen J ^d   Salsitz, Edwin A ^b   Kolodny, Andrew ^d   Whitley, Susan D ^c   Taubes, Tanaquil ^d   Seewald, Randy ^b   Joseph, Herman ^a   Kayman, Deborah J ^a   Fong, Chunki ^a   Marsch, Lisa A ^a   Rosenblum, Andrew ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NONE

Author keywords

Buprenorphine; Drug dependence treatment; Office based treatment; Opioids; Substance misuse

Indexed keywords

ALCOHOL; BUPRENORPHINE PLUS NALOXONE; DIAMORPHINE; OPIATE; BUPRENORPHINE; NARCOTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DISORDER; OPIATE ADDICTION; PRESCRIPTION; SUBSTANCE ABUSE; TREATMENT OUTCOME; ADOLESCENT; AMBULATORY CARE; COMORBIDITY; MENTAL DISEASE; MIDDLE AGED; PRIVATE PRACTICE; PSYCHIATRIC DIAGNOSIS; UNITED STATES;

ADOLESCENT; ADULT; AMBULATORY CARE; BUPRENORPHINE; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NARCOTICS; NEW YORK CITY; OPIOID-RELATED DISORDERS; PRIVATE PRACTICE;

EID: 34548426148     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v26n02_03     Document Type: Article

References (37)

1. SAMHSA. Overview of findings from the 2002 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2003.
2. Office of National Drug Control Policy. Heroin June 2003. http://www.whitehousdrugpolicy.gov (Accessed Jan 22, 2004).
3. SAMHSA The Treatment Episode Data Set (TEDS)-1997-2002. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2004a.
4. SAMHSA. DASIS Report. Treatment admissions involving narcotic pain killers: 2002 update. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2004b. http://www.oas.samhsa.gov/2k4/ painTX/painTX.htm (accessed June 6, 2005).
5. SAMHSA. ED Trends from DAWN-Final estimates 1995-2002. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2004c.
6. Roche T. The potent perils of a miracle drug. Time 47, 2000.
7. Koppel T. Nightline: the fight against pain. ABC News, 2005.
8. Adler J. In the grip of a deeper pain. Newsweek, October 20, 2003.
9. Meier B. Pain killer: A "wonder" drug's trial of addiction and death. Emmaus, PA: Rodale. 2003.
10. Fudala PJ, Jaffe JH, Dax EM, Johnson RE. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther 1990; 47(4):525-34.
11. Johnson RE, Jaffe J, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750-5.
12. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence N Engl J Med 2000; 343(18):1290-7.
13. Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomized, placebo-controlled trial. Lancet 2003; 361:662-8.
14. O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. JAMA 1998; 105:100-5.
15. Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D. Buprenorphine/Naloxone Collaborative Study Group. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349(10):949-58.
16. Bickel WK, Amass LA. Buprenorphine treatment of opioid dependence.Areview. Experimental and Clinical Psychopharmacology, 1995; 3: 477-89.
17. Stanton A, McLeod CC, Kissin W, Sonnefeld J, Luckey JW. Results from SAMHSA/CSAT's national evaluation of the buprenorphine waiver program. Presented at the College on Problems of Drug Dependence, Orlando, FL, June 20, 2005.
18. McLeod CC, Kissin WB, Stanton A, Sonnefeld J. SAMHSA/CSAT's evaluation of the buprenorphine waiver program, 30-day outcomes for buprenorphine patients treated by a national sample of qualified physicians. Presented at the College on Problems of Drug Dependence, Orlando, FL, June 20, 2005.
19. Colameco S, Armando J, Trotz C. Opiate dependence treatment with buprenorphine: one year's experience in a family practice residency setting. J Addict Dis. 2005; 24(2):25-32.
20. American Society of Addiction Medicine. Public policy statement on office-based opioid agonist treatment (OBOT). Journal of Addictive Diseases 2005; 24 (3):153-61.
21. Galanter M, Dermatis H, Resnick R, Maslansky R, Neumann E. Short-term buprenorphine maintenance: treatment outcome. J Addict Dis. 2003; 22(3):39-49.
22. Platt JJ. Heroin addiction: Theory, research and treatment. Malabar, FL: Kreiger, 1988.
23. Magura S, Kang SY, Rosenblum A, Handelsman L, Foote J. Gender differences in psychiatric comorbidity among cocaine-using opiate addicts. J Addict Dis 1998; 17:49-61.
24. Strain EC Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clin J Pain 2002; 18:S14-27.
25. Rosenblum A, Fong C, Magura S. Opioid prescription abuse among enrollees in opioid treatment programs. Presented at the American Association for the Treatment of Opioid Dependence, Atlanta, GA, April, 2006.
26. Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA. The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment? Drug Alcohol Depend. 2005 Jul; 79(1):113-6.
27. Fudala P, Walsh R, Ling P, Casadonte F, McSherry W, Willford J, Collins D, Raisch D, Kilby S, Saxon A, Johnson B, Ordorica P, Malkerneker U, Elkashef A. Office-based treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: results from a multicenter study. Presented at CPDD, Orlando, FL, June 2005.
28. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 1997; 54:71-80.
29. Miller NS. Psychiatric and comorbidity: prevalence in methadone maintenance treatment. Am J Drug and Alcohol Abuse 1996; 22:95-107.
30. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Arch Gen Psychiatry 1985; 42(11):1081-6.
31. Rounsaville BJ, Weissman MM, Kleber HD, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982; 39:161-6.
32. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. Arch Gen Psychiatry 1985; 42(11):1067-71.
33. Brands B, Blake J, Sproule B, Gourlay D Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment.Drug Alcohol Depen 200; 73:199-207.
34. McKay JR, Weiss RV. A review of temporal effects and outcomes predictors in substance abuse treatment studies with long-term follow-ups. Evaluation Review 2001; 25:113-61.
35. Magura S, Fong C, Staines GL, Cleland C, Foote J, Rosenblum A, Kosanke N, DeLuca A. The combined effects of treatment intensity, self-help groups and patient attributes on drinking outcomes. J Psychoactive Drugs. 2005; 37(1):85-92.
36. Vastag B. In-office opiate treatment "not a panacea": physicians slow to embrace therapeutic option. JAMA 2003; 290:731-5.
37. Becker WC, Fiellin DA. Provider satisfaction with office-based treatment of opioid dependence: A systematic review. Subst Abus. 2006; 26(1):15-22.